Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma.

British journal of cancer - 8 Jul 2008

Dahse R, Kosmehl H

Abstract excerpt

Activating mutations within the epidermal growth factor receptor (EGFR) identify lung adenocarcinoma patients with improved clinical responses to tyrosine kinase inhibitors gefitinib and erlotinib. By screening salivary gland carcinoma, two drug-sensitizing EGFR exon 19 delE746-A750 mutations were identified in an adenocystic and in a mucoepidermoid carcinoma of the parotid gland.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Adenoid Cystic
Share to DNA, Neoplasm
Share to Drug Resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Erlotinib Hydrochloride

Share to Gefitinib

Share to Protein Kinase Inhibitors

Share to Quinazolines

Source

Open in PubMed Open full text

Identifiers

PMID: 18542074
DOI: 10.1038/sj.bjc.6604430
PMCID: PMC2453031

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma.PMID 18542074Read ↗

Epidermal growth factor receptor kinase domain mutations are rare in salivary gland carcinomas.Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target.Semantic proximity Read ↗

Salivary gland carcinoma: Towards a more personalised approach.Semantic proximity Read ↗

[Salivary gland cancer: new therapeutic approaches].Semantic proximity Read ↗

KRAS status and epidermal growth factor receptor expression as determinants for anti-EGFR therapies in salivary gland carcinomas.Semantic proximity Read ↗

Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours.Semantic proximity Read ↗

Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.Semantic proximity Read ↗

Expression, Mutation, and Amplification Status of EGFR and Its Correlation with Five miRNAs in Salivary Gland Tumours.Semantic proximity Read ↗

Targeting human EGFR 2 (HER2) in salivary gland carcinomaSemantic proximity Read ↗

Detection of EGFR- and HER2-activating mutations in squamous cell carcinoma involving the head and neck.Semantic proximity Read ↗

No incidence of BRAF mutations in salivary gland carcinomas--implications for anti-EGFR therapies.Semantic proximity Read ↗

Mutational analysis of PI3K/AKT and RAS/RAF pathway activation in malignant salivary gland tumours with a new mutation of PIK3CA.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.